Overexpression of Insulin-like Growth Factor-1 in the Heart is Coupled with Myocyte Proliferation in Transgenic Mice
Overview
Affiliations
Transgenic mice were generated in which the cDNA for the human insulin-like growth factor 1B (IGF-1B) was placed under the control of a rat alpha-myosin heavy chain promoter. In mice heterozygous for the transgene, IGF-1B mRNA was not detectable in the fetal heart at the end of gestation, was present in modest levels at 1 day after birth, and increased progressively with postnatal maturation, reaching a peak at 75 days. Myocytes isolated from transgenic mice secreted 1.15 +/- 0.25 ng of IGF-1 per 10(6) cells per 24 hr versus 0.27 +/- 0.10 ng in myocytes from homozygous wild-type littermates. The plasma level of IGF-1 increased 84% in transgenic mice. Heart weight was comparable in wild-type littermates and transgenic mice up to 45 days of age, but a 42%, 45%, 62%, and 51% increase was found at 75, 135, 210, and 300 days, respectively, after birth. At 45, 75, and 210 days, the number of myocytes in the heart was 21%, 31%, and 55% higher, respectively, in transgenic animals. In contrast, myocyte cell volume was comparable in transgenic and control mice at all ages. In conclusion, overexpression of IGF-1 in myocytes leads to cardiomegaly mediated by an increased number of cells in the heart.
Fetal cardiac troponin I levels decline toward birth in sheep.
Jonker S, Louey S Am J Physiol Heart Circ Physiol. 2024; 326(6):H1538-H1543.
PMID: 38758126 PMC: 11380961. DOI: 10.1152/ajpheart.00224.2024.
Implications for neutrophils in cardiac arrhythmias.
Hegemann N, Barth L, Doring Y, Voigt N, Grune J Am J Physiol Heart Circ Physiol. 2023; 326(3):H441-H458.
PMID: 38099844 PMC: 11219058. DOI: 10.1152/ajpheart.00590.2023.
Leucine-973 is a crucial residue differentiating insulin and IGF-1 receptor signaling.
Nagao H, Cai W, Brandao B, Wewer Albrechtsen N, Steger M, Gattu A J Clin Invest. 2022; 133(4).
PMID: 36548088 PMC: 9927934. DOI: 10.1172/JCI161472.
Insulin Receptors and Insulin Action in the Heart: The Effects of Left Ventricular Assist Devices.
Pantazi K, Karlafti E, Bekiaridou A, Didagelos M, Ziakas A, Didangelos T Biomolecules. 2022; 12(4).
PMID: 35454166 PMC: 9024449. DOI: 10.3390/biom12040578.
Sonkar R, Berry R, Latimer M, Prabhu S, Young M, Frank S Front Pharmacol. 2022; 13:836725.
PMID: 35250583 PMC: 8888912. DOI: 10.3389/fphar.2022.836725.